Janine Small

Janine Small is the Global President for Pfizer Emerging Markets. In this role, she manages Pfizer’s broad pharmaceuticals portfolio and leads colleagues across Latin America, Asia, Africa and the Middle East who are focused on improving the health and well-being of people living in these regions. Under her leadership, the Emerging Markets business continues to innovate and partner with governments, non-governmental organizations, patients and others to increase appropriate access to Pfizer’s portfolio in core therapeutic areas, including vaccines, oncology, inflammation and immunology, internal medicine and rare disease as well as anti-infectives and sterile injectables used in and outside of the hospital setting. The business is also developing programs and partnerships with alliances, like Gavi, the Vaccine Alliance and UNICEF, which are improving health and quality of life in the poorest, underserved populations. Janine brings more than 30 years’ experience in the pharmaceutical industry, having joined Pfizer in 1988. She began her career in marketing in the United Kingdom and progressed to hold a number of leadership roles in Russia, Slovakia, Poland, Italy and Japan. In 2016, she became the Global Marketing Lead for Pfizer’s Essential Health (PEH) Business and then was named as the Regional President for PEH for the Asia Pacific region followed by an appointment as the Regional President for this business for Europe. Most recently, Janine was named Regional President for Pfizer Vaccines in the International Developed Markets where she worked to ensure millions of children and adults had access to vaccines that protect against infectious disease. She also led the worldwide government engagement for the Pfizer-BioNTech COVID-19 vaccine as part of the companies’ effort to address the global pandemic. Janine has been a Board member of the American Chamber of Commerce in several countries and sits on the board of Nova Medica (US-Russia Business Council) and Vaccines Europe, which represents companies involved in research and development (R&D), clinical trials, production and marketing of vaccines dedicated to improving public health through immunization. She earned a bachelor’s of science degree in Chemistry from Leeds University in the United Kingdom.